Bookbot

Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development

Solid Oral Dosage Forms

Parametri

  • 381pagine
  • 14 ore di lettura

Maggiori informazioni sul libro

Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products including the availability of raw materials, chemical purity. It also highlights constraints in generic drug development that differ from the formulation design of a brand name pharmaceutical product.

Acquisto del libro

Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development, Leon Shargel, Isadore Kanfer

Lingua
Pubblicato
2004
product-detail.submit-box.info.binding
(Copertina rigida),
Condizioni del libro
Danneggiato
Prezzo
38,57 €

Metodi di pagamento

Titolo
Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development
Sottotitolo
Solid Oral Dosage Forms
Lingua
Inglese
Editore
CRC Press
Pubblicato
2004
Formato
Copertina rigida
Pagine
381
ISBN10
0824754603
ISBN13
9780824754600
Serie
Descrizione
Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products including the availability of raw materials, chemical purity. It also highlights constraints in generic drug development that differ from the formulation design of a brand name pharmaceutical product.